Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment

David A. Loewenstein, Rosie E. Curiel, Steven DeKosky, Russell M. Bauer, Monica Rosselli, Salvador M. Guinjoan, Malek Adjouadi, Ailyn Peñate, William W. Barker, Sindy Goenaga, Todd Golde, Maria T. Greig-Custo, Kevin S. Hanson, Chunfei Li, Gabriel Lizarraga, Michael Marsiske, Ranjan Duara

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Objective Semantic intrusion (SI) errors may highlight specific breakdowns in memory associated with preclinical Alzheimer disease (AD); however, there have been no investigations to determine whether SI errors occur with greater frequency in persons with amnestic mild cognitive impairment (aMCI) confirmed as amyloid positive (Amy+) vs those who have clinical symptoms of aMCI-AD with negative amyloid scans (suspected non-AD pathology [SNAP]) or persons who are diagnosed with other brain disorders affecting cognition. Methods Eighty-eight participants with aMCI underwent brain amyloid PET and MRI scans and were classified as early AD (Amy+), SNAP (Amy−), or other neurological/psychiatric diagnosis (Amy−). We focused on SI on the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) targeting proactive semantic interference (PSI; old semantic learning interferes with new semantic learning), failure to recover from PSI after an additional learning trial (frPSI), and retroactive semantic interference (new semantic learning interferes with memory for old semantic learning). Results SIs on measures of PSI and frPSI distinguished between Amy+ AD and SNAP and other non-AD cases. PSI and frPSI intrusions evidenced moderately high associations with reduced volumes in the entorhinal cortex, superior temporal regions, and supramarginal gyrus. No such associations were observed in cases with SNAP. Conclusions SIs on the LASSI-L related to PSI and frPSI uniquely differentiated Amy+ and Amy− participants with aMCI and likely reflect deficits with inhibition and source memory in preclinical AD not captured by traditional cognitive measures. This may represent a specific, noninvasive test successful at distinguishing cases with true AD from those with SNAP.

Original languageEnglish (US)
Pages (from-to)E976-E984
JournalNeurology
Volume91
Issue number10
DOIs
StatePublished - Sep 4 2018

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment'. Together they form a unique fingerprint.

Cite this